Catalyst Wire Dossier Catalyst Wire Dossier

GI-5005

· GlobeImmune
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GI-5005, covering 2010-05-05 to 2014-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection [Phase 2]

See pricing